Flynn James E 13D/13G Filings for ImmunoGen, Inc. (IMGN)

Flynn James E 13D and 13G filings for ImmunoGen, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-10
09:44 am
Sale		 2022-12-31 13G ImmunoGen, Inc.
IMGN		 Flynn James E 6,358,314
2.880%		 -8,421,276decrease
(-56.98%)		 Filing
2022-05-19
4:50 pm
Purchase		 2022-05-09 13G ImmunoGen, Inc.
IMGN		 Flynn James E 14,779,590
6.700%		 14,779,590increase
(New Position)		 Filing